<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d474">
    <sentence id="DDI-DrugBank.d474.s0" text="Unless really needed, agents which may enhance the risk of hemorrhage should be discontinued prior to initiation of Lovenox Injection therapy.">
        <entity id="DDI-DrugBank.d474.s0.e0" charOffset="116-122"
            type="brand" text="Lovenox"/>
    </sentence>
    <sentence id="DDI-DrugBank.d474.s1" text="These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.">
        <entity id="DDI-DrugBank.d474.s1.e0" charOffset="42-55"
            type="group" text="anticoagulants"/>
        <entity id="DDI-DrugBank.d474.s1.e1" charOffset="58-76"
            type="group" text="platelet inhibitors"/>
        <entity id="DDI-DrugBank.d474.s1.e2" charOffset="88-107"
            type="drug" text="acetylsalicylic acid"/>
        <entity id="DDI-DrugBank.d474.s1.e3" charOffset="124-129"
            type="group" text="NSAIDs"/>
        <entity id="DDI-DrugBank.d474.s1.e4" charOffset="142-163"
            type="drug" text="ketorolac tromethamine"/>
        <entity id="DDI-DrugBank.d474.s1.e5" charOffset="167-178"
            type="drug" text="dipyridamole"/>
        <entity id="DDI-DrugBank.d474.s1.e6" charOffset="184-197"
            type="drug" text="sulfinpyrazone"/>
    </sentence>
    <sentence id="DDI-DrugBank.d474.s2" text="If co-administration is essential, conduct close clinical and laboratory monitoring"/>
    <sentence id="DDI-DrugBank.d474.s3" text="."/>
    <sentence id="DDI-DrugBank.d474.s4" text=""/>
</document>
